Here are relevant reports on : immuno-oncology-market
-
Immuno Oncology Assays Market Size, Share & Trends by Product & Service (Consumables, Instruments, Software), Technology (PCR, NGS, Immunoassay), Cancer Indications (Lung, Breast, Colorectal, Bladder, Melanoma), Application (Research, Diagnostics) - Global Forecast to 2026
The size of global immuno oncology assays market in terms of revenue was estimated to be worth USD 4.4 billion in 2021 and is poised to reach USD 7.9 billion by 2026, growing at a CAGR of 12.5% from 2021 to 2026. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights derived from conferences and webinars, identification of key stakeholders, and a nuanced understanding of market purchasing dynamics.
- Published: April 2021
- Price: $ 4950
- TOC Available:
-
Precision Diagnostics & Medicine Market by Diagnostic Testing (Genetic, DTC), Diagnostics Indication (Oncology, Neurology, Immunology), Therapeutic Products (Inhibitors, mAbs, CGT), Indication (Oncology, Rare Disease, Infectious) - Global Forecast to 2029
The global precision diagnostics and medicine market, valued at US$132.46 billion in 2023, stood at US$145.53 billion in 2024 and is projected to advance at a resilient CAGR of 11.1% from 2024 to 2029, culminating in a forecasted valuation of US$246.66 billion by the end of the period. Factors such as the growing integration of AI and ML to enhance precision diagnostics and medicine development supported by rising collaborations between pharmaceutical and diagnostics companies to improve precision healthcare and the rise in direct-to-consumer testing are driving the growth in the market.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Microcatheters Market by Type (Delivery, Diagnostic, Aspiration, Steerable), Design (Single, Dual), Application (Cardiovascular, Neurovascular, Peripheral Vascular, Oncology), End-User (Hospitals, Ambulatory Surgical Centers) - Global Forecast to 2028
The global microcatheters market in terms of revenue was estimated to be worth $874 million in 2023 and is poised to reach $1,142 million by 2028, growing at a CAGR of 5.5% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: July 2023
- Price: $ 4950
- TOC Available:
-
Embolotherapy Market by Product (Embolic Agents (Microspheres, Liquid Embolic Agents, Coil), Microcatheters), Indication (Oncology, Vascular, Aneurysm, Urology, Nephrology), Procedure (TACE, TARE), Enduser (Hospital, Clinics, ASC) - Global Forecast to 2026
The global embolotherapy market boasts a total value of $3.4 billion in 2021 and is projected to register a growth rate of 8.0% to reach a value of $5.0 billion by 2026. The major players in the market include Boston Medical Corporation (US), Terumo Medical Systems (Japan), Medtronic (US), Johnson & Johnson (US), and Stryker Corporation (US). Other key players in the embolization therapy market include Sirtex Medical Limited (US), Abbott Laboratories (US), Acandis GmbH (Germany), Balt (France), Cook Medical (US), Kaneka Corporation (Japan), Penumbra, Inc. (US), Merit Medical Systems (US), Meril Life Sciences Pvt. Ltd. (India), Cardiva (US), Shape Memory Medical Inc. (US), Artio Medical Inc. (US), Rapid Medical (US), Emboline, Inc. (US), and IMbiotechnologies Ltd. (Canada), among others.
- Published: May 2021
- Price: $ 4950
- TOC Available:
-
Targeted Protein Degradation Market by Type [PROTACs (Vepdegestrant, Bavdegalutamide), SERDs (Elacestrant), Molecular Glues (Mezigdomide), LDD, LYTAC/ATAC], Indication (Oncology, Inflammatory), Formulation (Oral), End User - Global Forecast to 2035
The global targeted protein degradation market, valued at US$0.01 billion in 2024, stood at US$0.48 billion in 2025 and is projected to advance at a resilient CAGR of 35.4% from 2025 to 2035, culminating in a forecasted valuation of US$9.85 billion by the end of the period. The Asia Pacific market is projected to grow at a significant CAGR during the forecast period, owing to increasing research & development activities for novel degraders.
- Published: August 2025
- Price: $ 4950
- TOC Available:
-
Latin America Electrosurgery Market by Product Type (Instruments, Accessories, Generators, Smoke Evacuation Systems), Surgery Type (Cardiovascular, Orthopedic, Cosmetic, Oncology, Urology, Neurosurgery), End User (Hospitals, ASCs) – Regional Forecast to 2031
The Latin America electrosurgery market, valued at USD0.31 billion in 2024, stood at USD0.33 billion in 2025 and is projected to advance at a resilient CAGR of 5.0% from 2025 to 2030, culminating in a forecasted valuation of USD0.44 billion by the end of the period. This market growth is driven by several factors, including an increase in surgical procedures, a growing elderly population, higher healthcare spending, and the rapid adoption of advanced energy platforms that prioritize safety in hospitals and specialty centers.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Enteral Feeding Devices Market, by Type (Administration sets, Nasogastric Tubes, Enteral Feeding Syringes, Nasal Feeding, Nasoduodenal), Insertion Method, Age Group (Adult, Pediatric), Application (Oncology, Respiratory), End User - Forecast to 2032
The Asia Pacific enteral feeding device market, valued at USD 0.76 billion in 2025, stood at USD 0.80 billion in 2026 and is projected to advance at a resilient CAGR of 6.8% from 2026 to 2032, culminating in a forecasted valuation of USD 1.20 billion by the end of the period. In the Asia Pacific enteral feeding devices market, the growth of enteral feeding tubes is primarily attributed to the incidence of diseases such as cancer, stroke, neurological disorders, and gastrointestinal diseases that often lead to swallowing difficulties and require prolonged nutrition support.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Optical Imaging Market by Product (Cameras, Lenses), Technique (OCT, HIS, NIR, PAT), Therapeutic Area (Ophthalmology, Dermatology, Oncology), Application (Pathological, Intraoperative), End User (Hospital, Research Labs) & Region - Global Forecast to 2027
The global optical Imaging market growth is primed to transition from USD 1.5 billion in 2022 to USD 2.9 billion by 2027, showcasing a strong CAGR of 13.5%. Precise differentiation between soft tissues and affected tissues, reduced patient exposure to eradicating radiations, increased prevalence of age related macular degeneration, increased GDP expenditure on healthcare among rapidly growing economies, increased need and adoption of non invasive tools for rapid scanning and identification of disorders coupled with increasing research to adopt these tools in the field of dentistry, gastroenterology, and gynecology are factors influencing the market growth and adoption of optical imaging systems.
- Published: February 2023
- Price: $ 4950
- TOC Available:
-
Epigenetics Market by Product (Kit [Antibodies, Reagents], Enzyme), Service (Single-Cell Epigenomics, Multi-omics), Method (DNA Methylation, Histone Modification), Technique (NGS, PCR, MS), Application (Oncology, Immunology, CVD) - Global Forecast to 2031
The global epigenetics market is projected to reach USD 3.92 billion by 2031, growing at a CAGR of 12.0% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
European Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90)), Application (Oncology, Thyroid, Cardiology), Procedures - Forecasts to 2020
Over the years, the European nuclear medicine/radiopharmaceuticals market has witnessed various advancements in radiopharmaceuticals. The European radiopharmaceuticals market is witnessing growth owing to an increasing number of radioisotope approvals for different clinical indications. Tc-99m and F-18 radioisotopes are estimated to contribute the highest to the European nuclear medicine diagnostic market in 2015, whereas Ra-223, I-131 and Y-90 ensured their leading position in the therapeutic market. The European nuclear medicine/radiopharmaceuticals market is expected to reach $1.62 Billion by 2020 from $1.09 Billion in 2015, growing at a CAGR of 8.2% from 2015 to 2020.
- Published: November 2015
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
